How the Oral Microbiome Affects Weight Management, Liver Health, and Diabetes Risk

Our dietary habits significantly impact our health, and the microorganisms residing in our mouths are equally crucial. A groundbreaking study investigating the relationship between the oral microbiome and metabolic health indicates that these findings could eventually help identify risks for obesity, prediabetes, and fatty liver disease.

“This represents one of the most ambitious efforts to correlate the oral microbiome with metabolic health across various organ systems,” noted Lindsay Edwards from King’s College London, who was not involved in the research.

The oral microbiome, the second largest microbial ecosystem in the body after the gut, has been linked to various health conditions. Previous research mainly focused on limited participants or single conditions, utilizing 16S ribosomal RNA profiling. While this method identifies broad microbial groups, it cannot specify bacterial strains or the genes they may carry.

In contrast, Imran Razak and his colleagues at the Mohammed bin Zayed University of Artificial Intelligence analyzed oral swabs from 9,431 participants using whole metagenomic sequencing, allowing for a comprehensive examination of all microbial DNA present. They paired this microbiome data with liver ultrasound scans, continuous blood glucose monitoring, and body composition analysis to create a robust statistical atlas. This atlas relates specific oral bacteria and their genes to 44 metabolic traits, such as liver fat, blood sugar fluctuations, and visceral fat, all relevant to conditions like high blood pressure, prediabetes, obesity, and fatty liver disease.

Many bacteria identified in this study have appeared in previous research. For instance, in early 2023, Ashish Jha from New York University Abu Dhabi reported that Streptococcus parasanguinis and Oribacterium sinus were more prevalent in obese individuals. Razak’s study corroborates these findings, linking these bacteria to increased BMI and body fat.

Additionally, new research has provided insights into microbial functions that may influence disease processes. For example, polyamine biosynthesis, associated with worse liver health and blood sugar control, as well as microbial pathways related to ceramide breakdown (lipids known to contribute to insulin resistance), were linked to adverse glycemic control.

Although the study does not definitively state that these bacteria cause health issues, Razak emphasizes that “bacteria serve as reliable indicators for future mechanistic studies.” The researchers hypothesize that the oral microbiome might not merely be a passive marker but may actively influence metabolic diseases.

Jha discusses potential pathways through which oral microbes might affect metabolic health, including the translocation of bacterial products into the bloodstream through inflamed gums, which can cause further inflammation. Oral microbes can also alter gut microbiota ecology and secrete chemicals that impact processes like blood sugar regulation and cardiovascular health.

Overall, the prevailing hypothesis suggests that it is not individual oral bacteria that lead to obesity or metabolic disorders, but rather “dysbiosis” of the oral microbiome, contributing to chronic inflammation and metabolic burdens through repeated microbial exposure, oral-gut transit, immune activation, and microbial metabolite production, as noted by Jha.

A puzzling aspect of this research is understanding why some individuals harbor potentially harmful microorganisms. Razak suggests that factors such as gum health, age, gender, smoking, and diet may all play a role. Notably, many associations persisted even when considering common oral health issues like periodontal disease.

Future studies that confirm these findings could enable the use of microbial signatures in the oral cavity as metrics for assessing metabolic risk. The prospect of a simple oral swab offering early warnings for conditions like fatty liver disease and blood sugar imbalances is particularly compelling, especially given the rising prevalence of metabolic disorders and the urgent need for non-invasive diagnostic tools, as highlighted by Edwards.

Adjusting the balance of these microorganisms may eventually become a viable therapeutic approach, Razak suggests.

While further research is needed to deepen our understanding of these associations and validate them across diverse populations, this study marks a significant advancement in microbiome research at a population level. It reinforces the growing recognition that the oral cavity is not only a reflection of oral health but may also act as a sentinel of systemic physiology, according to Edwards.